Shouyao Holdings Beijing Co. Ltd.SSE: 688197

Semi-annual Evaluation Report on "Corporate Value and Return Enhancement" Action Plan 2024

Aug 26, 2024 · Issued by Shouyao Holdings Beijing Co. Ltd. via Shanghai Stock Exchange

Filed with SSE · Aug 26, 2024

On 6ix: 6ix.com/news/semi-annual-evaluation-report-on-corporate-value-and-return-enhancement-action-plan-2024-3

Semi-annual Evaluation Report on "Corporate Value and Return Enhancement" Action Plan 2024

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:
View Attachment

6ix hasn’t read this filing yet.

Shouyao Holdings Beijing Co. Ltd. on 6ix

Earlier from Shouyao Holdings Beijing

Announcement on Convening Performance Meeting for 2023 and 1st Quarter of 2024Jun 8, 2024
Announcement on Resolutions of 2023 Annual General MeetingMay 30, 2024
Indicative Announcement on Report on Result of Shareholder' Inquiry Transfer, and Equity Changes of Shareholding Reduction by Shareholder with Over 5% Shares by 1% and Shareholding Reduction to Less than 5%May 25, 2024
Indicative Announcement on Pricing of Shareholders' Inquiry TransferMay 21, 2024
Notice on Convening 2023 Annual General MeetingMay 6, 2024

Later from Shouyao Holdings Beijing

Announcement on Participating in the 2024 Semi-annual Pharmaceutical and Biological Products Collective Performance BriefingSep 9, 2024
Announcement on Voluntary Disclosure of the Acceptance of New Drug Application for the ALK inhibitor Conteltinib (CT-707)Oct 23, 2024
Report for Q3 2024Oct 28, 2024
Announcement on Voluntary Disclosure of Adjustment to the Development Strategy of BTK Inhibitor SY-1530Nov 7, 2024
Announcement on Resolution of the 7th Meeting of the 2nd Board of DirectorsDec 11, 2024

All Shouyao Holdings Beijing news releases

Follow Shouyao Holdings Beijing into a list and get an email when it puts out news.

Follow Shouyao Holdings Beijing